As of Q3'25, RGTI reported R&D Expenses of USD 15M and SG&A Expenses of USD 5.9M, marking the latest data points in the quarterly operating expenses breakdown. This reflects a notable increase in R&D spending compared to the previous quarter, while SG&A Expenses saw a slight decrease. From Q4'22 to Q3'25, R&D Expenses exhibited a generally fluctuating trend, initially declining from USD 16M in Q4'22 to a low of USD 11M in Q1'24, before rebounding to USD 15M by Q3'25. SG&A Expenses followed a similar pattern, decreasing from USD 10M in Q4'22 to around USD 5.8M in Q3'24, with minor fluctuations thereafter. Overall, the chart demonstrates that R&D remains the dominant component of operating expenses, and both categories show periods of cost control followed by renewed increases in recent quarters.